Generation and modulation of hepatocellular carcinoma circulating cells: a new experimental model

The Journal of Surgical Research
Olivier ScattonAntoinette Lemoine

Abstract

To establish a new experimental model of human hepatocellular carcinoma by orthotopic implantation of tumoral cells with its subsequent removal, to generate and modulate circulating tumoral cells. Three human hepatoma cell lines (HepG2, PLC/PRF, and Mahlavu) were orthotopically implanted under the Glisson's capsule of the left lateral lobe of the liver in a total of 56 non-obese diabetic/severe combined immunodeficiency mice. Tumor removal was performed 30 d after injection, and a laparotomy without tumor removal was done in control mice. Generation of circulating cells was monitored by flow cytometry using fluorescein isothiocyanate-conjugated anti-HLA antibody. In 26 mice implanted with Mahlavu cells, 20 developed a unique tumor allowing a resection (77%), which was technically feasible in 80% of cases. The overall perioperative mortality was 30% (3/10) after resection; no mortality was observed in the control group. The circulating tumoral cells decreased dramatically after resection of the tumor as compared with control mice. This new model is feasible and may be an interesting useful tool to study the hepatocellular carcinoma metastatic process and is consistent with the human clinical practice.

References

Jan 1, 1989·Journal of Cancer Research and Clinical Oncology·H MujagićA Jevrić
Dec 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M MatsumuraY Shiratori
Mar 3, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M LouhaP Paterlini-Bréchot
Mar 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hitoshi YoshijiHiroshi Fukui
May 15, 2003·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Arin K Greene, Mark Puder
Dec 20, 2003·Journal of Cancer Research and Clinical Oncology·Zhao-You TangKang-Da Liu
Mar 23, 2004·Journal of Cancer Research and Clinical Oncology·Hui-Chuan Sun, Zhao-You Tang
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carolina ArmengolGabriel Capellá
Jun 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hitoshi YoshijiHiroshi Fukui
Oct 30, 2004·International Journal of Cancer. Journal International Du Cancer·Jean-Marc JosephGilles Vassal
May 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Esther RaskopfVolker Schmitz

❮ Previous
Next ❯

Citations

Jun 13, 2012·International Journal of Hepatology·Franck Chiappini
Jul 31, 2012·Cancer Letters·Li-Jun WuJian Wu
Oct 26, 2011·Nature Reviews. Gastroenterology & Hepatology·Yan LiJin-Xuan Hou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.